Redmile Group, LLC 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 8:01 pm Sale | 2024-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 2,895,478 4.800% | -302,013 (-9.45%) | Filing |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,197,491 5.300% | 500,843 (+18.57%) | Filing |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 2,696,648 4.500% | -1,181,951 (-30.47%) | Filing |
| 2023-02-14 4:28 pm Purchase | 2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,878,599 8.000% | 795,098 (+25.79%) | Filing |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,083,501 8.600% | -304,875 (-9.00%) | Filing |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,388,376 9.600% | -22,281 (-0.65%) | Filing |